We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.50 | 5.00 | 8.00 | 6.50 | 6.50 | 6.50 | 1,175 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:0991T ReGen Therapeutics PLC 10 December 2003 ReGen Therapeutics Plc 10th December 2003 ReGen Therapeutics Plc Placing raises #655,000 ReGen Therapeutics Plc ("ReGen" or "the Company") announces that it has today placed with new and existing shareholders 32.6 million new ordinary shares ("New Shares") at 2p per share to raise #652,000 before expenses ("Placing"). Application has been made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange Plc and dealings are expected to commence at 8am on 16th December 2003. Executive Chairman Percy Lomax commented "The Placing price of 2p is one third higher than the last placing in July and compares very favourably with the 0.75p placing price in April. During the current year the Company has raised #2.6m. I am very pleased to see the company in a financial position to continue the current Research and Development programme." For further information please contact: Andrew Marshall Marshall Robinson Roe Tel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange END IOEZBLFFXLBFFBQ
1 Year Argent Biopharma Chart |
1 Month Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions